Price Chart

DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
02/25/2022* -- Results Q4 2021 -- 0.89 --
02/25/2022* 08:30 EST Earnings Call Q4 2021 -- -- --
11/03/2021 -- Results Q3 2021 0.72 0.65 10.20%
11/03/2021 08:30 EST Earnings Call Q3 2021 -- -- --
08/03/2021 -- Results Q2 2021 0.77 0.74 4.22%
08/03/2021 08:30 EST Earnings Call Q2 2021 -- -- --
05/04/2021 -- Results Q1 2021 0.53 0.63 -16.03%
05/04/2021 08:30 EST Earnings Call Q1 2021 -- -- --
*Estimated Date/Time

Earnings

Next Report Date 02/25/2022
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 11/03/2021
Beat/Miss Upgrade
Return Since 13.48%
Last FQE 09/30/2021
Next FQE 12/30/2021

Profile

Edit
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for health care practitioners and their patients. The company has launched EXPAREL which utilizes DepoFoam, a product delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time.
URL https://www.pacira.com
Investor Relations URL https://investor.pacira.com/
HQ State/Province New Jersey
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Equity Style Small Cap/Growth
Next Earnings Release Feb. 25, 2022
Last Earnings Release Nov. 03, 2021
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Dividends

Dividend Per Share (TTM) --
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.00
Yield to Sector 0.00
Yield to Industry 0.00
Last Dividend Amt. --
Dividend Frequency --
Last Ex-Dividend Date --
Yield (TTM) 0%
Forward Yield --
Payout Ratio 0.00%
Cash Payout Ratio 0.00%
Consistent Payer (5Y) No
Consistent Growth (5Y) No

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2015
2016
2017
2018
2019
2020
2021
YTD
-13.39%
-57.94%
41.33%
-5.76%
5.30%
32.10%
0.55%
6.37%
1.38%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-5.89%
-15.83%
-73.64%
79.73%
5.67%
87.07%
50.46%
152.9%
-36.57%
--
--
--
--
--
-38.13%
16.96%
-5.66%
--
--
--
--
--
--
--
-42.04%
0.60%
-7.46%
-47.31%
-38.57%
-51.16%
168.7%
21.77%
-9.36%
As of January 20, 2022.

Profile

Edit
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for health care practitioners and their patients. The company has launched EXPAREL which utilizes DepoFoam, a product delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time.
URL https://www.pacira.com
Investor Relations URL https://investor.pacira.com/
HQ State/Province New Jersey
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Equity Style Small Cap/Growth
Next Earnings Release Feb. 25, 2022
Last Earnings Release Nov. 03, 2021
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

Symbol Dollars Invested % Weight
PJP 13.52M USD 3.98%
DFRIX 152.84M USD 3.36%
DSGFX 6.249M USD 3.12%
SPYGX 70.89M USD 2.80%
PSCH 10.33M USD 2.52%
XPH 5.179M USD 2.50%
PILL 392179.0 USD 1.79%
PXSAX 11.20M USD 1.70%
HRSGX 18.81M USD 1.66%
JSML 1.782M USD 1.48%
IHE 3.652M USD 0.94%
FESRX 1.175M USD 0.74%

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Morningstar Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Stocktwits PCRX Tweets